Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T-cell leukaemia-lymphoma

被引：19

作者：

Tokunaga, Masahito ^{[1
]}

Yonekura, Kentaro ^{[2
]}

Nakamura, Daisuke ^{[3
]}

Haraguchi, Kouichi ^{[4
]}

Tabuchi, Tomohisa ^{[5
]}

Fujino, Satoshi ^{[5
]}

Hayashida, Maiko ^{[5
]}

Maekawa, Kenichi ^{[5
]}

Arai, Akihiko ^{[4
]}

Nakano, Nobuaki ^{[1
]}

Kamada, Yuhei ^{[5
]}

Kubota, Ayumu ^{[1
]}

Inoue, Hirosaka ^{[5
]}

Owatari, Satsuki ^{[4
]}

Takeuchi, Shogo ^{[1
]}

Takatsuka, Yoshifusa ^{[1
]}

Otsuka, Maki ^{[4
]}

Hanada, Shuichi ^{[4
]}

Matsumoto, Tadashi ^{[3
]}

Yoshimitsu, Makoto ^{[5
,6
]}

Ishitsuka, Kenji ^{[5
,6
]}

Utsunomiya, Atae ^{[1
]}

机构：

[1] Imamura Bun In Hosp, Dept Haematol, Kagoshima, Japan

[2] Imamura Bun In Hosp, Dept Dermatol, Kagoshima, Japan

[3] Imamura Hosp, Dept Haematol, Kagoshima, Japan

[4] Natl Hosp Org Kagoshima Med Ctr, Dept Haematol, Kagoshima, Japan

[5] Kagoshima Univ Hosp, Dept Haematol & Immunol, Kagoshima, Japan

[6] Kagoshima Univ, Div Haematol & Immunol, Ctr Chron Viral Dis, Grad Sch Med & Dent Sci, Kagoshima, Japan

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 181卷 / 04期

关键词：

adult T-cell leukaemia-lymphoma; CC chemokine receptor 4; mogamulizumab; cutaneous adverse reaction; prognostic factor;

D O I：

10.1111/bjh.14634

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：539 / 542

页数：4

共 50 条

[1] Cutaneous Adverse Reaction to Mogamulizumab May Indicate Favourable Prognosis in Adult T-cell Leukaemia-lymphoma
Yonekura, Kentaro
Tokunaga, Masahito
Kawakami, Nobuyo
Takeda, Koichiro
Kanzaki, Tamotsu
Nakano, Nobuaki
Kubota, Ayumu
Takeuchi, Shogo
Takatsuka, Yoshifusa
Seto, Masao
Utsunomiya, Atae
ACTA DERMATO-VENEREOLOGICA, 2016, 96 (07) : 1000 - +
[2] Lenalidomide in adult T-cell leukaemia-lymphoma
Moskowitz, Alison J.
LANCET HAEMATOLOGY, 2016, 3 (03): : E100 - E101
[3] Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma
Winsett, Frank T.
Lewis, Daniel J.
Duvic, Madeleine
EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (09) : 757 - 760
[4] Clinical efficacy of mogamulizumab for relapsed/refractory aggressive adult T-cell leukemia/lymphoma: A retrospective analysis
Satake, Atsushi
Konishi, Akiko
Azuma, Yoshiko
Tsubokura, Yukie
Yoshimura, Hideaki
Hotta, Masaaki
Nakanishi, Takahisa
Fujita, Shinya
Nakaya, Aya
Ito, Tomoki
Ishii, Kazuyoshi
Nomura, Shosaku
EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (06) : 704 - 711
[5] Safety and effectiveness of mogamulizumab in relapsed or refractory adult T-cell leukemia-lymphoma
Ishitsuka, Kenji
Yurimoto, Satoshi
Tsuji, Yukie
Iwabuchi, Manabu
Takahashi, Takeshi
Tobinai, Kensei
EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (05) : 407 - 415
[6] Beneficial impact of first-line mogamulizumab-containing chemotherapy in adult T-cell leukaemia-lymphoma
Shichijo, Takafumi
Nosaka, Kisato
Tatetsu, Hiro
Higuchi, Yusuke
Endo, Shinya
Inoue, Yoshitaka
Toyoda, Kosuke
Kikukawa, Yoshitaka
Kawakita, Toshiro
Yasunaga, Jun-ichirou
Matsuoka, Masao
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (06) : 983 - 987
[7] Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma
Ishitsuka, Kenji
Tamura, Kazuo
LANCET ONCOLOGY, 2014, 15 (11): : E517 - E526
[8] Loss of CCR4 antigen expression after mogamulizumab therapy in a case of adult T-cell leukaemia-lymphoma
Ohno, Nobuhiro
Kobayashi, Seiichiro
Ishigaki, Tomohiro
Yuji, Koichiro
Kobayashi, Masayuki
Sato, Koota
Watanabe, Nobukazu
Tojo, Arinobu
Uchimaru, Kaoru
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (05) : 683 - 685
[9] Clinical significance of the immunoglobulin G heavy-chain repertoire in peripheral blood mononuclear cells of adult T-cell leukaemia-lymphoma patients receiving mogamulizumab
Nosaka, Kisato
Kusumoto, Shigeru
Nakano, Nobuaki
Choi, Ilseung
Yoshimitsu, Makoto
Imaizumi, Yoshitaka
Hidaka, Michihiro
Sasaki, Hidenori
Makiyama, Junya
Ohtsuka, Eiichi
Jo, Tatsuro
Ogata, Masao
Ito, Asahi
Yonekura, Kentaro
Tatetsu, Hiro
Kato, Takeharu
Kawakita, Toshiro
Suehiro, Youko
Ishitsuka, Kenji
Iida, Shinsuke
Matsutani, Takaji
Utsunomiya, Atae
Ueda, Ryuzo
Ishida, Takashi
BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (03) : 629 - 638
[10] The current status of therapy for adult T-cell leukaemia-lymphoma in Japan
Yamada, Y
Tomonaga, M
LEUKEMIA & LYMPHOMA, 2003, 44 (04) : 611 - 618

← 1 2 3 4 5 →